PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial, page-705

Timely communications and a responsive CEO/MD is always good! ☑️
I note Buckland didn't get back to you..
Just logged on to post an update about his data.

How many months in total has patients been treated for now ? Over a year?

Yep, agree!

From the OLE Study update, using that data:

12.6 months for the shortest duration patient, (if surviving)

and

21 months for the longest duration patient. (if surviving)

as of 4 July 2024.

That data is inaccurate.

You have mislead good people yet again.
.

Your announcement date is wrong.

Your dosage start dates are incorrect.

Your total dosage amounts are incorrect.

That data is misleading nonsense.
.

.

Having successfully ignored you for years,
I came out of ignore to post this, and mate you are back on ignore after posting this.

I think you owe @NZT a public apology.

Data points:

3 October 2022

https://hotcopper.com.au/threads/ann-first-patient-dosed-in-mnd-phase-1-2-trial.6995935/

&

6 January 2023

https://hotcopper.com.au/threads/ann-mnd-trial-successfully-completes-first-patient-cohort.7169251/

&

22 August 2023

https://hotcopper.com.au/threads/ann-additional-phase-1-data-suggest-mpl-may-inhibit-mnd.7537603/

cross-referenced with the OLE Study update:

5 June 2024

https://hotcopper.com.au/threads/ann-ole-study-update-reveals-impressive-survival-data.8037128/

regards,
Ice